Cyclo(D-Leu-L-Pro)

Catalog No.: 
ACVLDA393
CAS No.: 
36238-67-2
Molecular Formula: 
C11H18N2O2
Molecular Weight: 
210.28
Cyclo(D-Leu-L-Pro) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$136.00In stockInquiry
5mg98%$285.00In stockInquiry
10mg98%$457.00In stockInquiry
25mg98%$867.00In stockInquiry
50mg98%$1474.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameCyclo(D-Leu-L-Pro)
IUPAC Name(3R,8aS)-3-isobutylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione
Molecular FormulaC11H18N2O2
Molecular Weight210.28
SMILESO=C(N[C@@H]1CC(C)C)[C@@](CCC2)([H])N2C1=O
InChI KeySZJNCZMRZAUNQT-BDAKNGLRSA-N
Synonym(3R,8aS)-Octahydro-3-(2-methylpropyl)pyrrolo[1,2-a]pyrazine-1,4-dione;Cyclo[D-Leu-L-Pro-];(3R,8aS)-Hexahydro-3-(2-methylpropyl)pyrrolo[1,2-a]pyrazine-1,4-dione;Cyclo(L-prolyl-D-leucyl);Cyclo(S-Pro-R-Leu);Cyclo-L-prolyl-D-leucine;Hexahydro-3-(2-methylpropyl)-pyrrolo[1,2-a]pyrazine-1,4-dione;Cyclo(D-Leu-L-Pro)/Cyclo(L-Pro-D-Leu)
CAS No.36238-67-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACVLDA393 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVLDA393 route product structure diagram
    ACVLDA39336238-67-2In Stock
Inquiry

2. ACVLDA393 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVLDA393 route product structure diagram
    ACVLDA39336238-67-2In Stock
Inquiry

3. ACVLDA393 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVLDA393 route product structure diagram
    ACVLDA39336238-67-2In Stock
Inquiry

Comments (0)